Bayer’s Kerendia Gains Blockbuster Indication For Heart Failure

Bayer
Bayer gets a second indication for Kerendia, in heart failure • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business